Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Am Coll Emerg Physicians Open ; 3(6): e12858, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2172884
2.
J Emerg Med ; 59(6): 964-974, 2020 12.
Article in English | MEDLINE | ID: covidwho-1065311

ABSTRACT

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has contributed to an increase in intimate partner violence (IPV), posing challenges to health care providers who must protect themselves and others during sexual assault examinations. Victims of sexual assault encountered in prehospital and emergency department (ED) settings have legal as well as medical needs. A series of procedures must be carefully followed to facilitate forensic evidence collection and law enforcement investigation. A literature review detected a paucity of published guidance on the management of sexual assault patients in the ED, and no information specific to COVID-19. OBJECTIVE: Investigators sought to update the San Diego County sexual assault guidelines, created in collaboration with health care professionals, forensic specialists, and law enforcement, through a consensus iterative review process. An additional objective was to create a SAFET-I Tool for use by frontline providers during the COVID-19 pandemic. DISCUSSION: The authors present a novel SAFET-I Tool that outlines the following five components of effective sexual assault patient care: stabilization, alert system activation, forensic evidence consideration, expedited post-assault treatment, and trauma-informed care. This framework can be used as an educational tool and template for agencies interested in developing or adapting existing sexual assault policies. CONCLUSIONS: There is a lack of clinical guidance for ED providers that integrates the many aspects of sexual assault patient care, particularly during the COVID-19 pandemic. A SAFET-I Tool is presented to assist emergency health care providers in the treatment and advocacy of sexual assault patients during a period with increasing rates of IPV.


Subject(s)
Forensic Medicine/methods , Guidelines as Topic/standards , Sex Offenses/psychology , COVID-19/complications , COVID-19/epidemiology , California/epidemiology , Emergency Service, Hospital/organization & administration , Emergency Service, Hospital/trends , Forensic Medicine/standards , Forensic Medicine/trends , Humans , Pandemics/prevention & control , Physical Examination/adverse effects , Physical Examination/methods , Physical Examination/psychology , Sex Offenses/trends
3.
Disaster Med Public Health Prep ; 16(2): 434-437, 2022 04.
Article in English | MEDLINE | ID: covidwho-759542

ABSTRACT

The authors describe Taiwan's successful strategy in achieving control of coronavirus disease (COVID-19) without economic shutdown, despite the prediction that millions of infections would be imported from travelers returning from Chinese New Year celebrations in Mainland China in early 2020. As of September 2, 2020, Taiwan reports 489 cases, 7 deaths, and no locally acquired COVID-19 cases for the last 135 days (greater than 4 months) in its population of over 23.8 million people. Taiwan created quasi population immunity through the application of established public health principles. These non-pharmaceutical interventions, including public masking and social distancing, coupled with early and aggressive identification, isolation, and contact tracing to inhibit local transmission, represent a model for optimal public health management of COVID-19 and future emerging infectious diseases.


Subject(s)
COVID-19 , COVID-19/epidemiology , COVID-19/prevention & control , Contact Tracing , Humans , Public Health , SARS-CoV-2 , Taiwan/epidemiology
4.
Prehosp Disaster Med ; 35(4): 434-437, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-244550

ABSTRACT

The COVID-19 pandemic has strained health care system resources and reduced the availability of life-sustaining and medical-grade personal protective equipment (PPE) though the combination of increased demand and disrupted manufacturing supply chains. As a result of these shortages, many health care providers have temporarily used largely untested, improvised PPE (iPPE). Lack of quality control for makeshift PPE and frequent repurposing of used items to conserve supplies increase both the risk of provider infection and nosocomial spread to uninfected patients. One strategy to reduce risk of infection and preserve existing equipment is the implementation of secondary barrier devices placed directly over patients or providers. The authors describe an inexpensive, disposable, positive-pressure head isolation unit that can be rapidly constructed from materials readily available in nearly all health care settings for under five US dollars. The unit was successfully deployed in Taiwan during the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak, and again during the COVID-19 pandemic. The iPPE worn directly by the health care workers (HCWs) can be donned prior to patient contact in the presence of an air source. This strategy may be more protective than a covering placed over the patient in an aerosol-generating environment, which requires the HCW to be in close contact with the patient prior to securing the protective device.


Subject(s)
Coronavirus Infections/prevention & control , Disposable Equipment , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Pandemics/prevention & control , Personal Protective Equipment , Pneumonia, Viral/prevention & control , Aerosols/adverse effects , Betacoronavirus , Body Fluids/virology , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Disposable Equipment/economics , Equipment Design , Humans , Personal Protective Equipment/economics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , SARS-CoV-2 , Taiwan/epidemiology
5.
West J Emerg Med ; 21(2): 184-190, 2020 Jan 31.
Article in English | MEDLINE | ID: covidwho-14749

ABSTRACT

2019 Novel Coronavirus (2019-nCoV) is an emerging infectious disease closely related to MERS-CoV and SARS-CoV that was first reported in Wuhan City, Hubei Province, China in December 2019. As of January 2020, cases of 2019-nCoV are continuing to be reported in other Eastern Asian countries as well as in the United States, Europe, Australia, and numerous other countries. An unusually high volume of domestic and international travel corresponding to the beginning of the 2020 Chinese New Year complicated initial identification and containment of infected persons. Due to the rapidly rising number of cases and reported deaths, all countries should be considered at risk of imported 2019-nCoV. Therefore, it is essential for prehospital, clinic, and emergency department personnel to be able to rapidly assess 2019-nCoV risk and take immediate actions if indicated. The Identify-Isolate-Inform (3I) Tool, originally conceived for the initial detection and management of Ebola virus and later adjusted for other infectious agents, can be adapted for any emerging infectious disease. This paper reports a modification of the 3I Tool for use in the initial detection and management of patients under investigation for 2019-nCoV. After initial assessment for symptoms and epidemiological risk factors, including travel to affected areas and exposure to confirmed 2019-nCoV patients within 14 days, patients are classified in a risk-stratified system. Upon confirmation of a suspected 2019-nCoV case, affected persons must immediately be placed in airborne infection isolation and the appropriate public health agencies notified. This modified 3I Tool will assist emergency and primary care clinicians, as well as out-of-hospital providers, in effectively managing persons with suspected or confirmed 2019-nCoV.


Subject(s)
Betacoronavirus , Coronavirus Infections/diagnosis , Decision Support Techniques , Diagnosis, Differential , Emergency Service, Hospital , Pneumonia, Viral/diagnosis , Betacoronavirus/isolation & purification , COVID-19 , COVID-19 Testing , China , Clinical Laboratory Techniques , Communicable Diseases, Emerging , Coronavirus Infections/epidemiology , Emergency Medical Services , Europe , Humans , Pneumonia, Viral/epidemiology , Risk Factors , SARS-CoV-2 , Travel
SELECTION OF CITATIONS
SEARCH DETAIL